chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient called and stated she got the Moderna vaccine on Monday. She stated she has a hard knot and red raised circle about an inch wide at injection site. She stated it is sore to touch. RN stated to call her provider since it has been several days. She is not sure if the red circle started yesterday but it was there today. RN asked if she had any other side effects. She stated the same evening she got the shot she was feeling weak, and had a headache. She stated she took Tylenol, which she stated helped, but has a headache again today. RN stated to call doctor today so he may advise. RN stated will follow up with her tomorrow.
developed herpes zoster in his T4 area; experienced pain in the chest wall; local pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Oct-2021 and was forwarded to Moderna on 05-Oct-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of HERPES ZOSTER (developed herpes zoster in his T4 area), MUSCULOSKELETAL CHEST PAIN (experienced pain in the chest wall) and VACCINATION SITE PAIN (local pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included INFLUENZA VACCINE (FLU) for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (developed herpes zoster in his T4 area), MUSCULOSKELETAL CHEST PAIN (experienced pain in the chest wall) and VACCINATION SITE PAIN (local pain). At the time of the report, HERPES ZOSTER (developed herpes zoster in his T4 area) outcome was unknown, MUSCULOSKELETAL CHEST PAIN (experienced pain in the chest wall) had resolved and VACCINATION SITE PAIN (local pain) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported a week after flu shot he experienced chest wall pain and herpes zoster.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Oct-2021: Follow up received on  07-OCT-2021 has no new information
This spontaneous report as received from a registered nurse refers to a 62 years old male patient with WELLBUTRIN allergy, depression and sulfonamides allergy. The patient was intramuscularly vaccinated on left arm with lot # (672673/0492AE), 0.5 ml PNEUMOVAX 23 on 10-JUL-2012. Concomitant medications included LEXAPRO and omega-3 marine triglycerides. On 10-JUL-2012 the patient developed redness, swelling, pain, and muscle spasms 5 hours after administration. The patient was seen in the office on 11-JUL-2012 and it was noted that the reaction involved the entire circumference of the left upper arm. The patient was advised to apply ice compresses, BENADRYL cream, and cortisone cream to the area of reaction. The outcome of the patient was reported as not recovered/not resolved. No lab diagnostics study was performed. The nurse was requesting a lot check. This is one of several reports received from the same source. (MARRS#1207USA002943). Additional information has been requested.
Information has been received from a 13 year old female with seasonal allergies and reaction to skin allergy test, pertinent medical history of asthma, allergies, swollen optic nerve and elevated Thyroid Stimulating Hormone (TSH) and Antinuclear Antibody (ANA), who in October 2008, was vaccinated IM with GARDASIL all three doses (lot # not provided) for prevention of HPV and prevention of cervical cancer. Concomitant therapy included ADVAIR, PROAIR (as needed), antimicrobial (unspecified) and PROZAC. In October 2008, after the patient got GARDASIL, she had been back and forth to many doctors concerning swollen optic nerve, elevated ANA, elevated TSH and possible Auto immune disorder. Lab diagnostics studies performed included blood work, results were not provided by reporter. No further AE information was provided. The patient's swollen optic nerve, elevated ANA and TSH and Autoimmune disorder persisted. Follow-up information received from an other health professional concerning the female student with asthma, environmental allergy, anxiety disorder and no illness at time of vaccination, who on 27-OCT-2008 was vaccinated IM with a first dose of GARDASIL (lot # 660665/0279X). Secondary suspected therapy included flu vaccine (manufacturer unknown) on the same day. On 09-MAR-2009 (previously reported as October 2008), the patient was found to have elevated optic nerve on exam. Subsequently the patient had twice confirmed antinuclear antibody (ANA) increased and elevated anti-SSB antibody associated with Sjogren's syndrome but no eye symptoms. The patient's status was unknown. On 26-MAY-2009 the patient was vaccinated IM with a third dose of GARDASIL (lot # 660616/0570X). Additional information has been requested.
6/11 just a cough. This increased in force and frequency sometimes producing fluid, but mostly not. Fever at 100. 6/13 at home test positive. Reached out to Dr. by email initially. Doctor proscribed PAXLOVID and I took DELSYM cough syrup, and sugar free cough drops as needed.
Severe pain at site, angioedema, severe diarrhea, dyspnea with wheeze, all within 4 hrs of injection
Massive nose bleeds from left nostril on 5.17.21 and 5.18.21
Anemia; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 7-year-old female patient received BNT162b2 (BNT162B2), on 06Dec2021 as dose 2 (orange cap), single (Lot number: FK5127) at the age of 7 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma", start date: 15Dec2017 (unspecified if ongoing); "Atopic dermatitis", start date: 19Jun2020 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1, single, Batch/Lot number: FK5127, Anatomical Site of injection: Left arm, Route of administration: Intramuscular), administration date: 15Nov2021, for COVID-19 immunisation. The following information was reported: ANAEMIA (non-serious) with onset 16Feb2022, outcome "unknown", described as "Anemia".; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300157513 Same patient/same product, different dose/event;
COVID-19 INFECTION; This spontaneous report received from a consumer concerned a 62 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 infection was not reported. This report was non-serious. This case, from the same reporter is linked to 20220803967.
Fell in parking lot on way to registration area. Fell on L arm - used to brace fall. Denies dizziness  Vital Signs: HR 85 Resp 16 O2Sat 90  Skin Signs: Warm and dry  Circulation: Cap refill <2sec  Initial Treatment: Patient fell flat on back in parking lot/sidewalk. Assessment done before assisting patient to WC with help . Patient denies head, neck, or back injury/pain. States he did not hit his head. Denies dizziness. No open wounds or signs of injury. Taken to triage for observation.  Patient received vaccine without incident.  Disposition: Home by self with wife in own vehicle - escorted
Employee woke with sensory disturbance on left side of face itchy sensation, left eyelid and bottom lip droop, left ear pain.  She was ordered steroids by her PCP.
Patient seemed to have a vasovagal episode promptly following intramuscular administration of the Flucelvax influenza vaccine. Patient claimed to be dizzy and not feeling ok after needle was withdrawn from the left deltoid. Patient claimed that they felt as if they were about to pass out. Mother and father of patient were present to provide comfort to the patient. Patient proceeded to faint while simultaneously flexing their muscles giving an impression that they were having a seizure. Patient remained unconscious for approximately 20 seconds and then became responsive. Upon regaining consciousness patient was responsive to verbal stimuli but had a difficult time processing information. Patient kept repeating that they did not feel ok and occasionally seemed to lose consciousness briefly. Parent's father obtained water for the patient while I obtained an ice pack and some candy all three items were given to patient and they seemed to feel slightly better. I made it clear to the parents that they needed to take the patient to get evaluated and they left with him to go seek further medical attention. Patient was able to walk on his own out of the pharmacy.
Cant use her left arm; extremely painful/Painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Cant use her left arm) and VACCINATION SITE PAIN (extremely painful/Painful) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045C21A, 027B21A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In October 2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Cant use her left arm) and VACCINATION SITE PAIN (extremely painful/Painful). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Cant use her left arm) and VACCINATION SITE PAIN (extremely painful/Painful) had not resolved.            Concomitant drugs were not reported. Treatment medications were not provided.
Information has been received from a registered nurse via a mother concerning her son who was vaccinated on an unknown date with one dose of varicella virus vaccine live (Oka/Merck). On an unspecified date, post vaccination, the patient's mother "thinks" the patient had chickenpox. At the time of the report the patient's status was unknown. A product quality complaint was not involved. This is one of two reports received from same source. Additional information has been requested.
Pneumococcal vaccine given IM for PPD. Redness at site 2"x1.75" and 1 " going up arm towards axilla. Sent to MD. Ordered Zithromax 500mg PO stat, then qd for 4 days. Resolved by 11/01/2002.
Failing health since vaccine; she does not want to eat; She slept probably five hours during the day; She got up and she does not want to eat, she took a nap, she changed chairs and she took a nap; Her health has declined each day; She has more fatigue every day; In constant pain; Lost 20 LBS.; became weak and lightheaded; became weak and lightheaded; her immune system began to shut down; The initial safety information received was reporting only non-serious adverse drug reaction, Upon receipt of follow-up information on 26Mar2021, this case now contains serious adverse reactions. Information processed together.  This is a spontaneous report from a contactable consumer. A 92-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered in Arm on 04Feb2021 at 12:30 (Batch/Lot Number: EN5318) as single dose for COVID-19 immunization. Medical history included ongoing diabetes, arthritis and thyroid, all three for 10 plus years; and bladder. Concomitant medication included ongoing methotrexate and meloxicam taken for arthritis; metformin taken for diabetes; mirabegron taken for bladder; and levothyroxine taken for thyroid, all from an unspecified start date and ongoing. The patient received the vaccine on 04Feb2021 (reported as last Thursday afternoon) and everyday since then her health has declined each day. She has more fatigue every day and lightheaded. Her immune system began to shut down (several blood draws taken). She just wanted little afternoon nap. On Saturday, she wanted to do very little 'aero' (word not clear), very little just the minimum. She get up, she had a little breakfast, and as I live near a little pond, she watched the water and birds. And then yesterday, she slept probably five hours during the day and today that is all she has done, she got up and she does not want to eat, she took a nap, she changed chairs and she took a nap. She is now in her bedroom and taking another nap and this is not my mother. The patient was still alive but in failing health since the vaccine. The patient is now bedridden, lost 20 pounds (lbs) and was in constant pain. The patient was fine, walking and even dancing prior to vaccine.  The outcome of the events "Her health has declined each day" was not recovered while unknown for the other events. The patient died from vaccine on 15Mar2021. The autopsy was not done.  Follow-Up (02Apr2021): Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: Failing health since vaccine
Sore arms; Feels achy all over; Low grade fever of 100.3 degrees; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arms), MYALGIA (Feels achy all over) and PYREXIA (Low grade fever of 100.3 degrees) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 007B21A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Dec-2021, the patient experienced PAIN IN EXTREMITY (Sore arms), MYALGIA (Feels achy all over) and PYREXIA (Low grade fever of 100.3 degrees). At the time of the report, PAIN IN EXTREMITY (Sore arms) was resolving and MYALGIA (Feels achy all over) and PYREXIA (Low grade fever of 100.3 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Dec-2021, Body temperature: 100.3 (High) Low grade fever, 100.3 degrees.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.
Incorrect vaccine given:  PENTACEL MNF: Sanofi L# UJ102AAA Given IM Right Delt. Dose 0.5ML Order was for DTAP
Information has been received from a physician concerning a 15 year old male patient with allergic rhinitis with no drug reactions or allergies who on unspecified date, within the past month (in February 2011), was vaccinated with the first dose of GARDASIL (route, expiration date and lot number not reported). Concomitant therapy included VERAMYST. The physician reported that the patient experienced trouble breathing and appeared flushed at school, following the vaccination. The physician reported that the patient stated the the trouble breathing resolved with in 5-10 minutes. The patient did not receive treatment for the event. At the time of the report the outcome of the patient was unknown for the flushing. Follow up information has been received from a physician, concerning a 15 year old male student patient who at the time of vaccination was recovering from rhinitis and an infection which occurred "2 weeks ago" (approximately on 12-JAN-2011). On 26-JAN-2011 (previously reported as within the past month (in February 2011)) at 8:30 a.m., the patient was vaccinated in the left deltoid with the first dose of GARDASIL (Lot# 666948/0886Z, expiration date not provided). The physician reported that on 26-JAN-2011, the patient experienced trouble breathing and flushed face, which lasted for 5-10 min. On 26-JAN-2011, the patient recovered. The patient did not seek medical attention. No further information is available.
Contract covid between doses; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contract covid between doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contract covid between doses). At the time of the report, COVID-19 (Contract covid between doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported by reporter Treatment provided was Antibody IV infusion.   Reporter did not allow further contact
Menstrual cycle prolonged; Heavy menstrual bleeding; This spontaneous case was reported by a consumer and describes the occurrence of OLIGOMENORRHOEA (Menstrual cycle prolonged) and HEAVY MENSTRUAL BLEEDING (Heavy menstrual bleeding) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OLIGOMENORRHOEA (Menstrual cycle prolonged) and HEAVY MENSTRUAL BLEEDING (Heavy menstrual bleeding). At the time of the report, OLIGOMENORRHOEA (Menstrual cycle prolonged) and HEAVY MENSTRUAL BLEEDING (Heavy menstrual bleeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.   This case was linked to MOD-2021-245561 (Patient Link).
High fever (103+), Extreme and Excessive: Body aches, chills, shaking/convulsing as in seizure like, inability to speak or yell out, sweating.  Lasting approx 2-4 hours, was so bad I made my peace with God and thought I was going to die. Honestly.
I have Covid; I have Covid; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 ((PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1, via an unspecified route of administration on 09Mar2021 (Batch/Lot Number: EN6204) as a SINGLE DOSE for COVID-19 immunisation. The patient's medical and concomitant medications were not reported. The patient experienced "I have covid" on an unspecified date prior to the second dose of bnt162b2 (next dose was due 30Mar2021). The clinical outcome of the event drug ineffective and COVID-19 was unknown.
upper respiratory cough; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient in their 90's received BNT162b2 (BNT162B2), as dose 3 (booster), single (Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: COUGH (non-serious), outcome "unknown", described as "upper respiratory cough". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient had cold sore outbreak when requesting ZOSTAVAX. Cold sore symptoms were exacerbated after ZOSTAVAX injection. Pt. took acyclovir for cold sore, not knowing that he shouldn't take it for 14 days after shot. Patient with cold sore symptoms have resolved. Patient will discuss revaccination with doctor.
I woke up with a slight sore throat. A couple of days before I was tired with a headache. I completed a COVID-19 home test and it was positive. By 5:00 PM I had a fever of 102.5, body aches, congestion and headache. I developed a little cough after a couple of days. I went to the clinic on Saturday, and they prescribed PAXLOVID, and I started taking it the same day. My symptoms did improve but it took a little while. By Sunday I was still symptomatic. My fever was still slightly elevated. I ran a fever for another 7 days. I am still extremely fatigued and I still have a little cough.
This case was reported by a healthcare professional and described the occurrence of hepatitis b surface antigen negative in a 53-year-old female subject who was vaccinated with Engerix B for prophylaxis.  Concurrent vaccination included unspecified vaccine (PPD; manufacturer unspecified) given on 1 April 1999 and 9 August 2000.  On 9 August 2000, 3 May 1999 and 1 April 1999 the subject received 3rd dose, 2nd dose and 1st dose of Engerix B at 20 mcg.  On 24 July 2007, approximately 7 years after completing the Engerix B series, the subject was determined to be hepatitis b surface antigen negative and hepatitis b core antibody positive.  At the time of reporting the events were unresolved.
Swelling of lower lip and swelling of bilateral lower eyelids. This was noted the morning following vaccination. Resolved spontaneously over several hours without treatment. No other symptoms.